INTERNATIONAL PATENT: BERTIS INC, 주식회사 베르티스, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교 산학협력단 FILES APPLICATION FOR "BIOMARKER FOR DETERMINING SUBTYPE OF TRIPLE-NEGATIVE BREAST CANCER AND USE THEREOF"

Posted On: 2025-11-11

GENEVA, Nov. 11 -- BERTIS INC (B-301~302, D Tech Tower Gwacheon, 33 Gwacheon-daero 7-gilGwacheon-siGyeonggi-do 13840), 주식회사 베르티스 (경기도과천시과천대로7길 33, 디 테크타워 과천 B동 301,302호), SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-roGwanak-guSeoul 08826), 서울대학교 산학협력단 (서울특별시관악구관악로 1) filed a patent application (PCT/KR2025/005880) for "BIOMARKER FOR DETERMINING SUBTYPE OF TRIPLE-NEGATIVE BREAST CANCER AND USE THER...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BERTIS INC, 주식회사 베르티스, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교 산학협력단 FILES APPLICATION FOR "BIOMARKER FOR DETERMINING SUBTYPE OF TRIPLE-NEGATIVE BREAST CANCER AND USE THEREOF"